Introduction
It is believed that cancer arises from the stepwise accumulation of proto-oncogene and tumor suppressor gene mutations, and the progressive alteration of gene expression. One of the best-characterized model systems with respect to genetic changes that contribute to tumor initiation, tumor outgrowth and malignant progression is the mouse skin model of chemical carcinogenesis (Yuspa et al., 1994 , Frame et al., 1998 . Numerous benign papillomas develop on the dorsal skin of mice initiated by 7, 12-dimethylbenz(a)anthracene (DMBA) and promoted by 12-O-tetradecanoylphorbol-13-acetate (TPA). A small number of papillomas progress to form squamous cell carcinomas (SCCs), and spindle cell carcinomas (SpCCs) evolve late in carcinogenesis (Klein-Szanto et al., 1989) , associated with the downregulation of epithelial differentiation markers, such as E-cadherin and keratins, and the induction of mesenchymal components, such as vimentin (Navarro et al., 1991; Diaz-Guerra et al., 1992; Ruggeri et al., 1992; Stoler et al., 1993) . This phenomenon, referred to as epithelial-mesenchymal transformation (EMT), is considered a crucial event in late-stage tumorigenesis leading to a highly aggressive and metastatic type of tumor, and has also been observed in human cancer (Akhurst and Balmain, 1999; Thiery, 2002; Gotzmann et al., 2004) .
In the mouse skin carcinogenesis model, a specific activating A-T mutation at codon 61 of the H-Ras gene is involved in initiation of carcinogenesis (Quintanilla et al., 1986) , and amplification/overexpression of the mutant H-Ras gene or loss of the remaining wild-type H-Ras allele is associated with malignant progression (Quintanilla et al., 1986; Bremner and Balmain, 1990; Bianchi et al., 1990; Rodriguez-Puebla et al., 1999) . Specifically, in cases where both squamous and spindle cell components could be identified within the same tumor, both components had the same DMBA-specific H-Ras gene mutation, but the spindle cell component showed a higher mutant to normal gene ratio (Buchmann et al., 1991) . This, together with the demonstration that both epithelial and spindle cell types share the same point mutations in both alleles of p53, a gene whose inactivation occur in about 40% of SCCs, but not in premalignant papillomas (Burns et al., 1991) , provided a conclusive proof that SpCCs derive from pre-existing SCCs. In addition, it was found that loss or misregulation of the INK4 locus encoding the cell cycle regulators p15INK4B, p16INK4A and p19INK4A/ ARF correlated with the SCC-SpCC transition (Linardopoulos et al., 1995) . These genetic alterations might drive the spindle transformation in cooperation with other epigenetic events such as those triggered by transforming growth factor-b signaling pathways (Akhurst and Balmain, 1999) .
Aneuploidy -that is, an imbalance in the normal diploid complement of chromosomes -and chromosomal aberrations are hallmarks of experimental and human cancer. They occur early in tumor formation and increase with tumor progression, suggesting they can play a role in both tumor development and malignancy (Pihan and Doxsey, 1999; Rajagopalan et al., 2003; Grady, 2004) . In mouse skin carcinogenesis, aneuploidy and chromosomal abnormalities segregate with progressive dysplasia during malignant conversion from papillomas to SCCs (Conti et al., 1986; Aldaz et al., 1987) , and trisomies of chromosome 7 (where the H-Ras gene locus is located) and chromosome 6 have been found in aneuploid papillomas (Aldaz et al., 1989) .
In this article, we have identified a precursor cell subpopulation (CarC-R) within a highly aggressive spindle carcinoma cell line (CarC). CarC-R cells are epithelial in culture and weakly tumorigenic in nude mice, but produce highly undifferentiated carcinomas in vivo. CarC-R cells are aneuploid and exhibit a high degree of chromosomal instability. In contrast, CarC cells have a diploid or tetraploid modal number of chromosomes and are genetically more stable than CarC-R. A specific reciprocal chromosomal translocation T(14;15), which is associated with malignant progression, was characterized in CarC-R and CarC cells by spectral karyotyping (SKY) analysis and fluorescence in situ hybridization (FISH).
Results
The spindle carcinoma cell line CarC contains epithelial cells that exhibit phenotypic plasticity in vivo The CarC cell line was developed from a poorly differentiated mouse skin carcinoma induced by initiation with DMBA and promotion with TPA (Bremner and Balmain, 1990) . CarC cells are spindle shaped in culture, and produce highly anaplastic spindle carcinomas upon injection in nude mice (Buchmann et al., 1991; Diaz-Guerra et al., 1992) . Although CarC cell cultures have maintained a fibroblast-like appearance for more than 10 years (Figure 1 ), occasionally we observed the presence of isolated cells with an epithelial morphology in routine experiments in which CarC cells were passed at a high dilution. Thus, we isolated an epithelial cell subpopulation (CarC-R) from a late passage (>50) CarC cell culture seeded at low density (Figure 1 ). CarC-R cells were grown, frozen and studied as a separate cell Figure 1 Phase-contrast micrographs of the different cell lines. Bars, 100 mm T(14;15) and mouse skin tumor progression M Pons et al line. Characterization of protein differentiation markers revealed that CarC-R cells synthesize E-cadherin and keratins, while the expression of these epithelial protein markers was not detected in CarC cell lysates (Supplementary Figure 1) . Furthermore, E-cadherin in CarC-R cells was correctly located at cell-cell junctions, suggesting that it is actively mediating cellcell interactions. CarC-R cells have been found to maintain a stable epithelial phenotype for at least 40 passages.
The tumorigenic properties of CarC and CarC-R cells were compared after transplantation in nude mice. CarC cells gave rise to highly aggressive spindle tumors (Figure 2a and c) at all injection sites (six out of six) with short latencies (8-14 days). In contrast, CarC-R cells produced tumors in only 33% of injection sites (two out of six) after long latency periods (35-56 days). Histological examination of CarC-R tumors revealed that they were highly undifferentiated, with large areas exhibiting an apparent spindle morphology and small regions (o5%) containing epithelial cells with no squamous component (Figure 2b and d) . The fact that CarC-R cells switched from an epithelial phenotype in vitro to a mesenchymal phenotype when placed into a subcutaneous environment in vivo suggested that they were phenotypically plastic, able to undergo a reversible EMT in vitro and in vivo . Indeed, when a cell line (CarC-RT) was derived from an explanted tumor induced by CarC-RT, it exhibited a mixed morphology containing cells of both epithelial and fibroblastic appearances, which tended to present a predominant epithelial morphology when the culture was propagated. As expected, CarC-RT cells exhibited higher tumorigenic properties than CarC-R, inducing tumors at all injection sites (four out of four) with latency periods close to that of CarC (16-29 days). The CarC cell line was reported to contain a characteristic DMBA-associated A-T mutation in the codon 61 of the H-Ras gene and to have lost the normal H-Ras allele (Bremner and Balmain, 1990; Buchmann et al., 1991) . The H-Ras codon 61 mutation gives rise to a restriction site for XbaI, enabling an easy verification of the mutation by the presence of two novel restriction fragments after digestion of the DNA with the enzyme (Quintanilla et al., 1986) . We analysed the status of HRas in CarC and the other cell lines by RT-PCR, using primers that amplify a 400-bp sequence containing the codon 61. The amplified cDNA fragments were fractionated in a gel before and after digestion with XbaI. The PDV squamous carcinoma cell line containing an identical codon 61 mutation at H-Ras as CarC, but retaining the normal H-Ras allele , was used as a control. All of the cell lines exhibited the same XbaI polymorphism, but CarC-Rand CarC-RT-derived cell clones expressed increased normal to mutant ratios of H-Ras when compared with CarC ( Figure 3a) . In this latter cell line, although most of the amplified cDNA was digested by the enzyme, a faint band migrating to the normal position was observed after a careful inspection of the gel. This DNA was amplified by PCR and identified as normal H-Ras by sequencing (data not shown). These results suggest that CarC-R represents a small subpopulation of CarC cells that retain the normal H-Ras allele. All of the CarC-RT-derived clones expressed normal and mutated H-Ras transcripts irrespective of their phenotype, although the ratio of normal to mutated expression tended to be lower in the fibroblastic clones, particularly in the clone F2. CarC cells have also been reported to have deleted the genes encoding the cyclin-dependent kinase inhibitors p15INK4b and p16INK4a, an event associated with the late spindle stage of tumor progression in skin carcinogenesis (Linardopoulos et al., 1995) . The locus INK4a is also transcribed into a second alternate mRNA, which originates from an independent first exon, encoding p19ARF . To analyse the status of the INK4a locus in the cell lines, we studied the expression of p16 and p19 by RT-PCR and Western blotting. None of the cell lines expressed p16 mRNA (Figure 3b ) or protein ( Figure 3c ). However, while no expression of p19 could be detected in CarC, significant levels of p19 transcripts and protein were found in CarC-R-and CarC-RT-derived cell lines (Figure 3b and c). These results suggest that spindle CarC cells have inactivated the entire INK4a locus, while CarC-R and its derived cell lines might contain INK4a alterations that inactivate p16, but not p19 gene expression. Since silencing of the p16 INK4a promoter by methylation has been found in a significant fraction of human tumors (Ruas and Peters, 1998; Serrano, 2000) , we tested the effect of the methyltransferase inhibitor 5-aza-2 0 -deoxycytidine (5-aza-dC) on p16 expression. Western blot analysis showed that p16 protein was markedly upregulated in CarC-R, but not in CarC cells, after a 48 h treatment with the drug (Figure 3d ), indicating that inactivation of p16 gene transcription in CarC-R cells occurs by aberrant methylation of the promoter.
We also studied the status of the p53 gene in the cell lines. To this aim, exons 3-9 of the p53 sequence were amplified by RT-PCR and the resulting fragments purified and directly sequenced. This region contains the highly conserved DNA-binding core, where almost all mutations found in tumors occur (Vousden and Lu, 2002) . No change could be detected in CarC, CarC-R and CarC-RT-derived cell clones with respect to the normal sequence (Table 1) , while an ATG to GTG point mutation at codon 234 was found in PDV carcinoma cells, as described previously (Burns et al., 1991) .
Finally, in order to rule out the possibility that CarC-R represented some contaminating cells in the CarC cell line, we performed a microsatellite marker polymorphism analysis. Three chromosome 1 (D1Mit294, D1Mit383, D1Mit15) and two chromosome 12 (D12Mit199 and D12Mit180) microsatellite markers were amplified by PCR using specific primers. As shown in Supplementary Figure 2 , all CarC, CarC-R, F2 and E2 cell lines showed the same pattern of allelic bands.
Characterization of chromosomal abnormalities by SKY
Karyotypic analysis of the cell lines revealed that CarC had a diploid or tetraploid modal chromosome number ( Figure 4) and most of the aneuploid cells with nonmodal chromosome numbers were near-diploid (40-50), near-tetraploid (71-90) or near-octaploid (close to 160). In contrast, CarC-R and CarC-RT-derived cell clones were highly aneuploid. CarC-R, with a mode of 66 chromosomes, was highly homogeneous with regard to the karyotype of individual cells, since about 72% of the cells had 61-70 chromosomes (Figure 4 ). Clones derived from CarC-RT were more heterogeneous than CarC-R and had modal chromosome numbers ranging from 84 to 102 (data not shown).
In order to study whether specific chromosomal aberrations correlated with the phenotype or tumorigenic characteristics of the cell lines, we carried out a SKY analysis in CarC, CarC-R and two clones of each phenotype, either epithelial or fibroblastic (Table 2 ). All metaphases analysed in CarC showed the same T(14;15) reciprocal translocation (Figure 5a and b) , and about 25% of the cells had in addition a T(11;19) translocation. The T(14;15) translocation was found to segregate with tumors induced by CarC in nude mice (data not shown). While these were the only significant chromosomal aberrations found in CarC cells, CarC-R and CarC-RT-derived clones exhibited a wide variety of chromosomal abnormalities with the presence of Robertsonian translocations, deletions, insertions, amplifications, and gains and losses of chromosomes (Table 2 and Figure 5c ). No specific alteration associated with either the epithelial or the fibroblastic phenotype was observed in the cell clones. Interestingly, we were unable to detect the T(14;15) translocation in CarC-R cells with this method, even though we increased the number of analysed metaphases up to 63. However, T(14;15) was recurrent in all of the studied CarC-RT-derived cell clones (Table 2 ). Since CarC-RT cells come from a tumor produced by CarC-R in a nude mouse after a long latency period, these results suggested that T(14;15) should be present in a small subpopulation of CarC-R cells that was selected in vivo during tumor formation.
T(14;15) segregates with tumorigenicity
To confirm the above hypothesis, we carried out a FISH approach to analyse specifically the T(14;15) Exons 3-9 of the p53 gene were amplified by RT-PCR and directly sequenced T(14;15) and mouse skin tumor progression M Pons et al translocation in a higher number of CarC-R metaphases. Dual-color FISH combining bacterial artificial chromosome (BAC) probes mapping at regions C, D1, D3 and E3 of chromosome 15 (Figure 6a ) was then performed in CarC-R, CarC-RT and CarC cells. As expected, most of CarC-RT and CarC metaphases contained a translocated chromosome 15 (Table 3) , while it was present in only a small proportion of CarC-R cells (Table 3 and Figure 6b ). In all cases, the breakpoint in chromosome 15 was between regions D1 and D3, again indicating a common origin for all of these cell lines. To confirm that a portion of chromosome 15 was swapped with chromosome 14, we chose a BAC probe mapping at region A3 close to the chromosome 14 centromere, together with BACs C and E3 of chromosome 15 (Figure 6c ). The A3 probe gave a diffuse spot (green) after hybridization, enabling distinction between this region in chromosome 14 and region C from chromosome 15. The finding of a translocated product containing the A3 fragment of chromosome 14 fused to the E3 region derived from chromosome 15 as well as a product derived from chromosome 15 that had lost the E3 region in the same metaphase (Figure 6c and d) unequivocally demonstrated the presence of a reciprocal T(14;15) translocation in CarC-R, as found previously in CarC and CarC-RT-derived cell clones by SKY. The dual-color metaphase FISH also revealed that T(14;15) was absent from premalignant MCA3D keratinocytes (data not shown), which are nontumorigenic upon injection in nude mice , and served as a negative control. A summary of the detection of T(14;15) by FISH in CarC-R, CarC-RT and CarC cells is presented in Table 3 . Overall, the data of Tables 2 and 3 indicated that only 1.9% of CarC-R cells contained the T(14;15) translocation (five out of 263 metaphases), while it was widely distributed in CarC-RT and CarC cell populations with more than 90% of metaphases displaying T(14;15). The above results indicate that T(14;15) translocation segregates with tumorigenicity, since it was present in only a minority of CarC-R cells that were selected in vivo in the mouse to produce a tumor.
Discussion
In this report, we have characterized a cell subpopulation (CarC-R) contained in a spindle carcinoma cell line (2), T(2;3), Rb(3.18), T(9;19), Hsr(11), T(14;15), Rb(7.17) F4 10 68-102, Del(X), Rb(3.18), T(4;10), Is(10;13;4), Rb(6.10), T(5;18), T(X;8;11), Hsr(11), T(1;9), T(14;15), Rb(17.17) E2 8 74-91, T(2;3), Rb(3.18), T(4;10), Is(10;13;4), Hsr(11), T(14;15) E4 10 65-108, Del(X), T(X;X), T(2;3), T(4;10), Hsr(11), T(14;15)
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Both CarC-R and CarC cell lines contain the same DMBA-specific A-T mutation at codon 61 of the H-Ras gene, which is associated with the initiation of carcinogenesis (Quintanilla et al., 1986) . However, while CarC-R cells retain the normal H-Ras allele, it is lost in CarC spindle cells. Increased mutant to normal H-Ras ratios (or loss of the normal H-Ras allele) is a frequent characteristic associated with the SCC-SpCC transition in vivo (Buchmann et al., 1991) . Thus, fibroblastic cell clones derived from an explanted CarC-RT tended to express increased mutant to normal H-Ras transcript levels in comparison with epithelial cell clones derived from the same tumor. In particular, reduced expression of normal H-Ras was more evident in F2 cells. H-Ras is considered a major driving force for tumor progression in mouse skin carcinogenesis. The mutant H-Ras allele is frequently duplicated in papillomas and amplified to multiple copies or overexpressed in SCCs (Bremner and Balmain, 1990; Bianchi et al., 1990; Rodriguez-Puebla et al., 1999) . Thus, successive increases in Ras activity appear to correlate with malignant potential, but this model requires downregulation or loss of downstream signals that would lead to growth arrest or cell death by enhanced Ras oncogenic activity such as p16INK4a and p19INK4a/ARF (Frame and Balmain, 2000) . In fact, deletions in the INK4 locus are frequent events associated with the late spindle stage of tumor progression, and CarC cells were found to have deleted the p15INK4b and p16INK4a genes (Linardopoulos et al., 1995) . The INK4a locus encodes two transcripts, p16 and p19, originating from an alternate first exon and common second and third exons (Duro et al., 1995; Mao et al., 1995; Stone et al., 1995) . The finding that CarC spindle cells do not express p16 and p19 genes indicates that they have deleted the entire INK4a locus. In contrast, CarC-R cells express p19 mRNA and protein, but they have silenced p16 transcriptional activity, likely by promoter methylation. These results suggest that sequential inactivation of p16 and p19 occurs at later stages of tumor progression, the latter associated with the acquisition of a full malignant phenotype. This important role of p19 in malignancy is confirmed by genetically engineered mouse models, where the inactivation of p19, but not p16, predisposes to the development of spontaneous tumors (reviewed in Serrano, 2000; Sherr, 2001 ). In particular, regarding the susceptibility of these mice to DMBA-induced carcinogenesis, p16-deficient mice showed a similar frequency of skin tumors than wild-type mice (Sharpless et al., 2001) , while in p19-deficient mice, the number and growth rate of papillomas was increased, and progression to highly aggressive SpCCs was accelerated (Kelly-Spratt et al., 2004) .
In addition to the above genetic alterations, we have identified in this work a reciprocal T(14;15) translocation, which is widely distributed in the CarC cell population, but present in only a minority (1.9%) of CarC-R cells. T(14;15) is selected in vivo in tumors induced by CarC-R in nude mice, indicating that it is associated with malignancy. The fact that T(14;15) segregates with both epithelial and fibroblast clonal derivatives of CarC-RT indicates that it is not related to a particular phenotype. Although a T(14;15) was observed in a spontaneous thymic lymphoma developed in a mouse deficient for both histone H2AX and p53 (Celeste et al., 2003) , to our knowledge T(14;15) translocations have not been found before in mouse epithelial tumors. The chromosome 15 breakpoint was mapped between clones RP23-236P20 (region D1) and RP23-6B22 (region D3), still separated by a long distance of approximately 17 Mb. Further studies are in progress to delineate the precise location of breakpoints in chromosomes 15 and 14, and to determine whether rearrangements of specific genes are involved in the translocation. c-myc, which is associated with recurrent T(15;12) translocations in pro-B-cell lymphomas (Difilippantonio et al., 2002; Celeste et al., 2003) , is located at 62.2 Mb in band D3 of chromosome 15 (http://www.ensembl.org), a region that could be involved in T(14;15). However, we have not observed significant changes in c-myc expression in the cell lines that could be related to this translocation (data not shown).
The finding that CarC and CarC-R cell lines carry the same mutation at the H-Ras gene, together with the presence of the same T(14;15) translocation and absence of mutations in the central core of the p53 gene argues in favor of a common origin, likely clonal for both cell lines. Furthermore, CarC-R appears to represent a stage previous to CarC in malignant progression, as suggested by their respective tumorigenic and phenotypic characteristics and the presence in CarC of additional genetic alterations, that is, loss of the normal H-Ras allele, deletion of the INK4a/ARF locus and spread of T(14;15), which are associated with tumor progression in vivo. Nevertheless, the relationship between these two cell lines is not clear at present. CarC-R cells with a near-triploid (61-70) number of chromosomes are aneuploid and exhibit a wide variety of chromosomal aberrations. In contrast, most CarC cells are neardiploid or near-tetraploid and are characterized by a single specific T(14;15) chromosomal translocation (and by a secondary T(11;19) translocation, which is present in only about 25% of the cells). These results support previous reports showing an intimate relationship between chromosomal instability and the degree of aneuploidy (Lengauer et al., 1997 (Lengauer et al., , 1998 Takahashi et al., 1999; Miyoshi et al., 2000; Beheshti et al., 2001) . Both events appear to occur early in tumorigenesis and even precede malignant transformation (Duesberg et al., 1998 (Duesberg et al., , 1999 Shih et al., 2001) , and some authors have proposed that genomic instability drives the tumorigenic process probably by permitting the accumulation of mutations in proto-oncogenes and tumor suppressor genes (see, for example, Grady, 2004) . CarC cells could derive from the small CarC-R cell subpopulation that contains the T(14;15) translocation. Since no cell with T(14;15) could be found in CarC-R by SKY, it was not possible to determine whether these minority CarC-R cell subpopulation was aneuploid, like the vast majority of CarC-R cells, or near-diploid/tetraploid as CarC. However, in vivo selection of CarC-R cells containing T(14;15) appears to indicate that many of these cells are in fact aneuploid, as seen by the karyotypes displayed by CarC-RT-derived cell clones. Particularly, the clone F2 that recapitulates some of the characteristics of CarC cells, such as a spindle phenotype, increased mutant to normal H-Ras dosage, widespread distribution of T(14;15) and a strong tumorigenic potential in nude mice (data not shown), is aneuploid and exhibits a high degree of chromosomal instability. Alternatively, CarC and CarC-R rather than being part of a linear relationship could represent distinct products in the evolutionary process of the tumor. However, the fact that near-diploid/tetraploid spindle CarC cells are the major subpopulation in the CarC cell line raises the question of whether aneuploidy and genomic instability are important primary events needed for tumorigenesis but dispensable for maintenance of a fully developed malignant phenotype.
Materials and methods

Cell lines, culture conditions and drug treatment
To obtain the CarC-R cell line, CarC cells (passage>50) were seeded at low density in 100 mm plastic dishes, and a colony of cells displaying an epithelial morphology (CarC-R) was isolated by a cloning ring. CarC-R cells were grown, expanded to several flasks and frozen. The CarC-RT cell line was isolated from an explanted tumor induced by subcutaneous injection of CarC-R cells into the back of a nude mouse. Clones F2, F3, F4, F5, E1, E2 and E4 were isolated from an early-passage (passage ¼ 2) CarC-RT cell culture by cloning rings. Other cell lines used in this work were premalignant MCA3D and transformed PDV mouse keratinocytes (Fusenig et al., 1978; Kulesz-Martin et al., 1983) . Cells were grown in Ham's F-12 medium supplemented with amino acids and vitamins (MCA3D, PDV) or Dulbecco's modified Eagle's medium (CarC, CarC-R, CarC-RT cells and CarC-RT-derived clones), in the presence of 10% fetal calf serum (Gibco Invitrogen Corp., Barcelona, Spain) and antibiotics (100 mg/ml ampicillin, 32 mg/ml gentamicin; 25 mg/ml amphotericin B; Sigma-Aldrich, Madrid, Spain). Cultures were maintained at 371C in a 5% CO 2 humidified atmosphere.
The methyltransferase inhibitor 5-aza-dC (Sigma-Aldrich) was used to test the effect of demethylation on p16 gene expression. Cells were treated with either 10 mM 5-aza-dC or the same volume of ethanol (used as a solvent for the drug) for 48 h. After treatment, cells were washed in PBS and harvested for Western blot analysis.
RT-PCR analysis
RNA samples (2 mg) isolated from the cell lines by the guanidinium thiocyanate procedure were incubated with the Moloney murine leukemia virus reverse transcriptase (Promega Corp., Madison, WI, USA), and the generated cDNAs were used for PCR amplification. For specific detection of mouse p16 and p19 mRNAs, we used oligonucleotides to amplify fragments corresponding to exon 1a (133 bp) and exon 1b (205 bp) of the INK4a locus, as well as primers to amplify the entire coding region of p16 (516 bp) and p19 (586 bp). For mouse H-Ras, oligonucleotides to amplify a cDNA fragment containing the codon 61 were used. The 400-bp product was isolated using a gel extraction kit (QIAquick; QuiagenGmbH, Hilden, Germany). The presence of a DMBA-specific A-T mutation at codon 61 was verified by digestion of the DNA with XbaI (Gibco Invitrogen Corp.), as reported previously (Quintanilla et al., 1986) . For p53, oligonucleotides to amplify a cDNA fragment containing exons 3-9 were used. The 928-bp product was isolated and directly sequenced in an ABI PRISM 377 machine (PE Applied Biosystems, Foster city, CA, USA). See Supplementary Information for specific primers and PCR conditions.
Western blot analysis
Specific proteins were detected by using enhanced chemiluminescence (Amersham Corporation, Arlington Heights, FL, USA) and the following primary antibodies: rabbit polyclonal anti-p16 (1 : 250) (Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA), rabbit polyclonal anti-p19 (1 : 500) (raised against amino acids 54-75; kindly provided by Dr I Palmero, Instituto de Investigaciones Biome´dicas, CSIC-UAM, Madrid, Spain) and mouse monoclonal anti-a-tubulin DM1A (1 : 10000) (Sigma Aldrich). As secondary antibodies, anti-mouse or anti-rabbit IgGs coupled to horseradish peroxidase (Nordic Immunological Laboratories, Tilburg, The Netherlands) were used.
Cytogenetic studies, SKY and FISH analysis
For conventional cytogenetic analysis, cells were exposed to colchicine (0.5 mg/ml) for 6 h at 371C, and harvested routinely. Metaphases were analysed after standard Giemsa staining, Cbanded and DAPI staining, as described (Bella et al., 1995) .
For SKY analysis, slide preparation and hybridization, using commercial probes, were carried out according to the manufacturer's instructions (Applied Spectral Imaging (ASI), Migdal Ha'Emek, Israel). Images were acquired using an ASI SD300 Spectracube mounted on a Zeiss Axioplan 2 microscope.
For FISH studies, Ensembl Cytoview was used to select BAC clones covering regions C, D1, D3 and E3 from chromosome 15, and region A3 from chromosome 14. Clones were purchased from the Children Hospital Oakland Research Institute (CHORI; www.chori.org/bacpac/) and used for FISH analysis. All BACs were labeled directly by nick translation with SpectrumGreen-or SpectrumOrange-dUTPs, according to the manufacturer's specifications (Vysis, Dowers Grove, IL, USA). The probes were blocked with mouse Cot-1 DNA (Gibco Invitrogen Corp.) to suppress repetitive sequences. Metaphase spreads from the cell lines were hybridized overnight at 371C with labeled probes. After posthybridization washes, the chromosomes were counterstained with DAPI in antifade solution. Cell images were captured using a CCD camera (Photometrics SenSys camera) connected to a computer running the Chromofluor image analysis system (Cytovision, Applied Imaging Ltd, Newcastle, UK).
Tumorigenicity assay
For tumorigenicity assays, 3 Â 10 6 viable cells were intradermally injected into the two flanks of 8-week-old female athymic BALB/c nude mice (Harlan SL, Barcelona, Spain). The latency period was estimated as the time needed for tumors to reach a size of 1 cm 2 . Histological typing of developed tumors was performed in formalin-fixed and paraffin-embedded sections by staining with hematoxylin and eosin.
